Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.
暂无分享,去创建一个
[1] K. Hagino-Yamagishi,et al. [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.
[2] J. Laterra,et al. Targeting the c-Met Pathway Potentiates Glioblastoma Responses to γ-Radiation , 2005, Clinical Cancer Research.
[3] E. Stathopoulos,et al. Bone marrow microvascular density and angiogenic growth factors in multiple myeloma , 2004, Clinical chemistry and laboratory medicine.
[4] O. Arrieta,et al. Coexpression of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor cMET predict recurrence of meningiomas. , 2004, Cancer letters.
[5] Lothar Schweigerer,et al. Hepatocyte Growth Factor/c-Met Signaling Promotes the Progression of Experimental Human Neuroblastomas , 2004, Cancer Research.
[6] Viatcheslav R Akmaev,et al. Vascular gene expression in nonneoplastic and malignant brain. , 2004, The American journal of pathology.
[7] L. Naldini,et al. Targeting the tumor and its microenvironment by a dual-function decoy Met receptor. , 2004, Cancer cell.
[8] M. Lenter,et al. Human primary co-culture angiogenesis assay reveals additive stimulation and different angiogenic properties of VEGF and HGF. , 2004, Cytokine.
[9] S. Ryter,et al. Hepatocyte Growth Factor Protects against Hypoxia/Reoxygenation-induced Apoptosis in Endothelial Cells* , 2004, Journal of Biological Chemistry.
[10] W. Birchmeier,et al. Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.
[11] L. Tacchini,et al. Hepatocyte growth factor signaling regulates transactivation of genes belonging to the plasminogen activation system via hypoxia inducible factor-1. , 2003, Experimental cell research.
[12] J. Christensen,et al. A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. , 2003, Cancer research.
[13] O. Volpert,et al. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[14] T. Blundell,et al. Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Gerritsen,et al. Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells , 2003, British journal of pharmacology.
[16] M. Westphal,et al. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] K. Müller,et al. Impact of c-Met expression on angiogenesis in soft tissue sarcomas: correlation to microvessel-density , 2003, Journal of Cancer Research and Clinical Oncology.
[18] Z. Han,et al. HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. , 2003, Blood.
[19] M. Westphal,et al. Glioblastoma and Cerebral Microvascular Endothelial Cell Migration in Response to Tumor-associated Growth Factors , 2003, Neurosurgery.
[20] Toshikazu Nakamura,et al. NK4 (HGF‐antagonist/angiogenesis inhibitor) in cancer biology and therapeutics , 2003, Cancer science.
[21] Y. Taniyama,et al. Angiogenic Property of Hepatocyte Growth Factor Is Dependent on Upregulation of Essential Transcription Factor for Angiogenesis, ets-1 , 2003, Circulation.
[22] R. Kaufmann,et al. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription , 2003, Journal of Cell Science.
[23] J. Wood,et al. Hepatocyte Growth Factor/Scatter Factor Can Induce Angiogenesis Independently of Vascular Endothelial Growth Factor , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[24] J. Fallon,et al. Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques. , 2002, Atherosclerosis.
[25] D. Edwards,et al. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). , 2002, Journal of cell science.
[26] K. Jahng,et al. Hepatocyte growth factor upregulates thymosin β4 in human umbilical vein endothelial cells , 2002 .
[27] R. Ondarza,et al. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma , 2002, Cancer.
[28] K. Purdie,et al. Hepatocyte growth factor-induced endothelial cell motility is mediated by the upregulation of inducible nitric oxide synthase expression. , 2002, Cardiovascular research.
[29] K. Walter,et al. Scatter Factor/Hepatocyte Growth Factor Stimulation of Glioblastoma Cell Cycle Progression through G1 Is c-Myc Dependent and Independent of p27 Suppression, Cdk2 Activation, or E2F1-Dependent Transcription , 2002, Molecular and Cellular Biology.
[30] Bonnie LaFleur,et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease , 2001, Nature Genetics.
[31] G. V. Vande Woude,et al. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[32] A. Larsson,et al. Angiogenesis and angiogenic growth factors in Wilms tumor. , 2001, The Journal of urology.
[33] T. Ogihara,et al. Contribution of Bcl-2, but Not Bcl-xL and Bax, to Antiapoptotic Actions of Hepatocyte Growth Factor in Hypoxia-Conditioned Human Endothelial Cells , 2001, Hypertension.
[34] P. Schirmacher,et al. Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas. , 2001, Neuro-oncology.
[35] L. Rangell,et al. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. , 2001, The American journal of pathology.
[36] W. Jiang,et al. Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] Y. Taniyama,et al. Mitogenic and Antiapoptotic Actions of Hepatocyte Growth Factor Through ERK, STAT3, and Akt in Endothelial Cells , 2001, Hypertension.
[38] K. Matsumoto,et al. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. , 2000, Cancer research.
[39] K. Kinzler,et al. Genes expressed in human tumor endothelium. , 2000, Science.
[40] J. Williams,et al. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. , 2000, Cancer research.
[41] J. Keiser,et al. Hepatocyte growth factor enhances MMP activity in human endothelial cells. , 2000, Biochemical and biophysical research communications.
[42] E. Rosen,et al. Scatter Factor as a Tumor Angiogenesis Factor : Eliot M. Rosen Long Island Jewish Medical Center, New Hyde Park, and Albert Einstein College o f Medicine, Bronx, New York Katrin Lamszus, Saijun Fan, and Itzhak D. Goldberg , 1999 .
[43] G. Rubanyi. Angiogenesis in Health and Disease: Basic Mechanisms and Clinical Applications , 1999 .
[44] K. Matsumoto,et al. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[45] H. Dietz,et al. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. , 1999, Journal of the National Cancer Institute.
[46] S. Sato,et al. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. , 1999, Cancer.
[47] M. Westphal,et al. Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas , 1999, International Journal of Developmental Neuroscience.
[48] T. Nakamura,et al. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[49] M. Westphal,et al. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis , 1999, International journal of cancer.
[50] C. Birchmeier,et al. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. , 1998, Trends in cell biology.
[51] H. Kataoka,et al. Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. , 1998, Biochemical and biophysical research communications.
[52] S. Nakano,et al. Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans. , 1998, Cancer letters.
[53] J. Isner,et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. , 1998, Circulation.
[54] A. Bardelli,et al. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway , 1998, Nature.
[55] Marlys Witte,et al. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells , 1998, International journal of cancer.
[56] E. Hudson,et al. Met and hepatocyte growth factor/scatter factor expression in human gliomas. , 1997, Cancer research.
[57] L. Schmidt,et al. Activating mutations for the met tyrosine kinase receptor in human cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[58] E. Rosen,et al. Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth. , 1997, Biochemical and biophysical research communications.
[59] S. Scherer,et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas , 1997, Nature Genetics.
[60] E. Rosen,et al. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[61] L. Jin,et al. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[62] M. Weinand,et al. Scatter factor expression and regulation in human glial tumors , 1996, International journal of cancer.
[63] M. Aoki,et al. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. , 1996, Biochemical and biophysical research communications.
[64] M. Aoki,et al. Expression of local hepatocyte growth factor system in vascular tissues. , 1995, Biochemical and biophysical research communications.
[65] Tetsuo Noda,et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor , 1995, Nature.
[66] M. Sharpe,et al. Scatter factor/hepatocyte growth factor is essential for liver development , 1995, Nature.
[67] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[68] J. Delattre,et al. Oncogene amplification in human gliomas: a molecular cytogenetic analysis. , 1994, Oncogene.
[69] A. Bardelli,et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family , 1994, Cell.
[70] C. Birchmeier,et al. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development , 1993, The Journal of cell biology.
[71] K. Miyazawa,et al. Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. , 1993, The Journal of biological chemistry.
[72] H. Kleinman,et al. Scatter factor induces blood vessel formation in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[73] H. Ito,et al. Frequent amplification of the c-met gene in scirrhous type stomach cancer. , 1992, Biochemical and biophysical research communications.
[74] L. Naldini,et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth , 1992, The Journal of cell biology.
[75] N. Fausto. Hepatocyte growth factor receptor and the c-met oncogene Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802?804 , 1991 .
[76] T. Nakamura,et al. Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable. , 1991, Journal of cell science.
[77] W. Birchmeier,et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[78] T. Nakamura,et al. Organization of the human hepatocyte growth factor-encoding gene. , 1991, Gene.
[79] J. Rubin,et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.
[80] K. Tashiro,et al. Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.
[81] M. Perryman,et al. An epithelial scatter factor released by embryo fibroblasts. , 1985, Journal of cell science.
[82] C. Cooper,et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line , 1984, Nature.
[83] T. Nakamura,et al. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. , 1984, Biochemical and biophysical research communications.
[84] W. Jiang,et al. Regulation of angiogenesis and endothelial cell motility by matrix-bound fibroblasts , 2004, Angiogenesis.
[85] H. Dietz,et al. Design and expression of chimeric U1/ribozyme transgenes. , 2004, Methods in molecular biology.
[86] S. Elledge,et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease , 2003, Nature Genetics.
[87] K. Jahng,et al. Hepatocyte growth factor upregulates thymosin beta4 in human umbilical vein endothelial cells. , 2002, Biochemical and Biophysical Research Communications - BBRC.
[88] D. Grant,et al. Angiogenesis as a component of epithelial-mesenchymal interactions. , 1995, EXS.
[89] D. W. Vinter,et al. Smooth muscle-derived factor stimulates mobility of human tumor cells. , 1990, Invasion & metastasis.
[90] B. Davidson,et al. The FASEB Journal express article 10.1096/fj.01-0421fje. Published online November 29, 2001. , 2022 .